Maurizio Bonati is professor of public health at the Istituto di Ricerche Farmacologiche Mario Negri IRCSS in Milan, Italy.
Maurizio Bonati
Professor
Istituto di Ricerche Farmacologiche Mario Negri IRCCS
From this contributor
Clinicians should consider off-label treatments for autism
Clinicians need a more consistent and evidence-based approach to prescribing antipsychotics to children and adolescents with autism.
Clinicians should consider off-label treatments for autism
By
Maurizio Bonati
7 May 2019 | 5 min read
Explore more from The Transmitter
Oregon primate research center to downsize monkey colony, pivot to non-animal models
The center’s host university had been negotiating with the federal government about converting the center into an animal sanctuary. A new plan, approved today, preserves some of the center’s nonhuman primate studies.
Oregon primate research center to downsize monkey colony, pivot to non-animal models
The center’s host university had been negotiating with the federal government about converting the center into an animal sanctuary. A new plan, approved today, preserves some of the center’s nonhuman primate studies.
By
Calli McMurray
27 July 2026 | 5 min read
A planetarium for the brain
Tyler Sloan’s new film, more than a decade in the making, takes viewers on an immersive journey.
A planetarium for the brain
Tyler Sloan’s new film, more than a decade in the making, takes viewers on an immersive journey.
By
Emily Singer
27 July 2026 | 1 min watch
Neuroscientists weigh in on White House proposal for ‘moonshot infrastructure’ for connectomics
A report from the Trump administration calls for a “new golden age” of science, in which the federal government supports mission-driven collaborations to deliver high returns on research investments.
Neuroscientists weigh in on White House proposal for ‘moonshot infrastructure’ for connectomics
A report from the Trump administration calls for a “new golden age” of science, in which the federal government supports mission-driven collaborations to deliver high returns on research investments.
By
Sarah Thau
24 July 2026 | 4 min read